New perspectives with interferon alpha. The German CML study group experience

Bone Marrow Transplant. 1994:14 Suppl 3:S14-20.
No abstract available

Publication types

  • Review

MeSH terms

  • Busulfan / therapeutic use
  • Clinical Trials as Topic
  • Humans
  • Hydroxyurea / therapeutic use
  • Interferon-alpha / therapeutic use*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Survival Rate

Substances

  • Interferon-alpha
  • Busulfan
  • Hydroxyurea